Overall rank by patents
#35,637
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B21D (Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal).
The verdict
According to USPTO PatentsView, Harbin ranks #35,637 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 12 technology areas.
USPTO PatentsView assignee plate
Corpus R35637 · Foreign Corporation #35,637 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Hansa Biopharma AB (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Harbin Institute OF… · this assignee
46 score
3D Lighting… · lowest
7 score
What this shows Harbin's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Harbin Institute OF Technology, Weihai is a focused PatentsView assignee: 12 CPC subclasses with 57.1% of grants classified under B21D (Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2017. By volume, Harbin sits between Hansa Biopharma AB and Harumoto Technology (SHEN ZHEN) Co., Ltd..
Harbin Institute OF Technology, Weihai shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hansa Biopharma AB
7 patents
Hanseo University Academic Cooperation Foundation
7 patents
Hanwha Advanced Materials Corporation
7 patents
Happe Spine, LLC
7 patents
Hardrock Offroad LLC
7 patents
Harmony Helper, LLC
7 patents
Harmotec Co., Ltd.
7 patents
Harumoto Technology (SHEN ZHEN) Co., Ltd.
7 patents
Harbin Institute OF Technology, Weihai
7 patents
What this shows Harbin holds 7 patents at rank #35,614, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,614 in granted patent volume.
Other assignees with the most granted patents in Harbin's primary technology class.
Harbin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 14.3% |
| 2022 | 2 | 28.6% |
| 2023 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
| 2025partial year | 2 | 28.6% |
Top 12 of 12 technology areas
Overall rank by patents
#35,637
of 49,997 tracked assignees
46.0 out of 100
What to do with this data
Harbin Institute OF Technology, Weihai's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.